Odonate, Inc. (ODTC)

Market Cap	48.56M
Revenue (ttm)	n/a
Net Income (ttm)	-102.07M
Shares Out	2.84K
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Open	17,100
Previous Close	17,050
Day's Range	17,100 - 17,100
52-Week Range	2,850 - 49,895
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Odonate

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2013
• Employees: 145
• Stock Exchange: OTCMKTS
• Ticker Symbol: ODTC